DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer

<h3>Background</h3><p dir="ltr">Colorectal cancer (CRC) is the third most commonly diagnosed human malignancy worldwide. Upregulation of inhibitory immune checkpoints by tumor-infiltrating immune cells (TIICs) or their ligands by tumor cells leads to tumor evasion from ho...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Varun Sasidharan Nair (5396393) (author)
مؤلفون آخرون: Salman M. Toor (8854751) (author), Rowaida Z. Taha (8854754) (author), Hibah Shaath (5599658) (author), Eyad Elkord (5396390) (author)
منشور في: 2018
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513513538453504
author Varun Sasidharan Nair (5396393)
author2 Salman M. Toor (8854751)
Rowaida Z. Taha (8854754)
Hibah Shaath (5599658)
Eyad Elkord (5396390)
author2_role author
author
author
author
author_facet Varun Sasidharan Nair (5396393)
Salman M. Toor (8854751)
Rowaida Z. Taha (8854754)
Hibah Shaath (5599658)
Eyad Elkord (5396390)
author_role author
dc.creator.none.fl_str_mv Varun Sasidharan Nair (5396393)
Salman M. Toor (8854751)
Rowaida Z. Taha (8854754)
Hibah Shaath (5599658)
Eyad Elkord (5396390)
dc.date.none.fl_str_mv 2018-08-06T18:00:00Z
dc.identifier.none.fl_str_mv 10.1186/s13148-018-0539-3
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/DNA_methylation_and_repressive_histones_in_the_promoters_of_PD-1_CTLA-4_TIM-3_LAG-3_TIGIT_PD-L1_and_galectin-9_genes_in_human_colorectal_cancer/25920100
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Colorectal cancer
Immune checkpoints
PD-L1
Galectin-9
DNA methylation
Histone trimethylation
dc.title.none.fl_str_mv DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">Colorectal cancer (CRC) is the third most commonly diagnosed human malignancy worldwide. Upregulation of inhibitory immune checkpoints by tumor-infiltrating immune cells (TIICs) or their ligands by tumor cells leads to tumor evasion from host immunosurveillance. Changes in DNA methylation pattern and enrichment of methylated histone marks in the promoter regions could be major contributors to the upregulation of immune checkpoints (ICs) in the tumor microenvironment (TME).</p><h3>Methods</h3><p dir="ltr">Relative expressions of various immune checkpoints and ligands in colon normal tissues (NT) and colorectal tumor tissues (TT) were assessed by qRT-PCR. The epigenetic modifications behind this upregulation were determined by investigating the CpG methylation status of their promoter regions using bisulfite sequencing. Distributions of histone 3 lysine 9 trimethylation (H3K9me3) and histone 3 lysine 27 trimethylation (H3K27me3) in promoter regions of these genes were assessed by chromatin immunoprecipitation (ChIP) assay.</p><h3>Results</h3><p dir="ltr">We found that the expression levels of PD-1, CTLA-4, TIM-3, TIGIT, PD-L1, and galectin-9 were significantly higher in colorectal tumor tissues, compared with colon normal tissues. To study the role of DNA methylation, we checked the promoter CpG methylation of ICs and ligands and found that only CTLA-4 and TIGIT, among other genes, were significantly hypomethylated in TT compared with NT. Next, we checked the abundance of repressive histones (H3K9me3 and H3K27me3) in the promoter regions of ICs/ligands. We found that bindings of H3K9me3 in PD-1 and TIGIT promoters and H3K27me3 in CTLA-4 promotor were significantly lower in TT compared with NT. Additionally, bindings of both H3K9me3 and H3K27me3 in the TIM-3 promoter were significantly lower in TT compared with NT.</p><h3>Conclusion</h3><p dir="ltr">This study shows that both DNA hypomethylation and H3K9me3 and H3K27me3 repressive histones are involved in upregulation of CTLA-4 and TIGIT genes. However, repressive histones, but not DNA hypomethylation, are involved in upregulation of PD-1 and TIM-3 genes in CRC tumor tissue. These epigenetic modifications could be utilized as diagnostic biomarkers for CRC.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Epigenetics<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s13148-018-0539-3" target="_blank">https://dx.doi.org/10.1186/s13148-018-0539-3</a></p>
eu_rights_str_mv openAccess
id Manara2_79fc436dd2ac26e9f47f01c557bee586
identifier_str_mv 10.1186/s13148-018-0539-3
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25920100
publishDate 2018
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancerVarun Sasidharan Nair (5396393)Salman M. Toor (8854751)Rowaida Z. Taha (8854754)Hibah Shaath (5599658)Eyad Elkord (5396390)Biomedical and clinical sciencesImmunologyOncology and carcinogenesisColorectal cancerImmune checkpointsPD-L1Galectin-9DNA methylationHistone trimethylation<h3>Background</h3><p dir="ltr">Colorectal cancer (CRC) is the third most commonly diagnosed human malignancy worldwide. Upregulation of inhibitory immune checkpoints by tumor-infiltrating immune cells (TIICs) or their ligands by tumor cells leads to tumor evasion from host immunosurveillance. Changes in DNA methylation pattern and enrichment of methylated histone marks in the promoter regions could be major contributors to the upregulation of immune checkpoints (ICs) in the tumor microenvironment (TME).</p><h3>Methods</h3><p dir="ltr">Relative expressions of various immune checkpoints and ligands in colon normal tissues (NT) and colorectal tumor tissues (TT) were assessed by qRT-PCR. The epigenetic modifications behind this upregulation were determined by investigating the CpG methylation status of their promoter regions using bisulfite sequencing. Distributions of histone 3 lysine 9 trimethylation (H3K9me3) and histone 3 lysine 27 trimethylation (H3K27me3) in promoter regions of these genes were assessed by chromatin immunoprecipitation (ChIP) assay.</p><h3>Results</h3><p dir="ltr">We found that the expression levels of PD-1, CTLA-4, TIM-3, TIGIT, PD-L1, and galectin-9 were significantly higher in colorectal tumor tissues, compared with colon normal tissues. To study the role of DNA methylation, we checked the promoter CpG methylation of ICs and ligands and found that only CTLA-4 and TIGIT, among other genes, were significantly hypomethylated in TT compared with NT. Next, we checked the abundance of repressive histones (H3K9me3 and H3K27me3) in the promoter regions of ICs/ligands. We found that bindings of H3K9me3 in PD-1 and TIGIT promoters and H3K27me3 in CTLA-4 promotor were significantly lower in TT compared with NT. Additionally, bindings of both H3K9me3 and H3K27me3 in the TIM-3 promoter were significantly lower in TT compared with NT.</p><h3>Conclusion</h3><p dir="ltr">This study shows that both DNA hypomethylation and H3K9me3 and H3K27me3 repressive histones are involved in upregulation of CTLA-4 and TIGIT genes. However, repressive histones, but not DNA hypomethylation, are involved in upregulation of PD-1 and TIM-3 genes in CRC tumor tissue. These epigenetic modifications could be utilized as diagnostic biomarkers for CRC.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Epigenetics<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s13148-018-0539-3" target="_blank">https://dx.doi.org/10.1186/s13148-018-0539-3</a></p>2018-08-06T18:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s13148-018-0539-3https://figshare.com/articles/journal_contribution/DNA_methylation_and_repressive_histones_in_the_promoters_of_PD-1_CTLA-4_TIM-3_LAG-3_TIGIT_PD-L1_and_galectin-9_genes_in_human_colorectal_cancer/25920100CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/259201002018-08-06T18:00:00Z
spellingShingle DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
Varun Sasidharan Nair (5396393)
Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Colorectal cancer
Immune checkpoints
PD-L1
Galectin-9
DNA methylation
Histone trimethylation
status_str publishedVersion
title DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
title_full DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
title_fullStr DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
title_full_unstemmed DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
title_short DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
title_sort DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
topic Biomedical and clinical sciences
Immunology
Oncology and carcinogenesis
Colorectal cancer
Immune checkpoints
PD-L1
Galectin-9
DNA methylation
Histone trimethylation